Table 3.
Characterizations of the optimum formulae of the studied nanosystems.
| Route | Topical |
Ocular |
Vaginal | |||
|---|---|---|---|---|---|---|
| Nanosystem | T-T-NV | T-CE | O-NV | O-OLN | O-TP | V-TP |
| EE % | 100.00 ± 1.10 | 83.00 ± 1.63 | 94.31 ± 2.75 | 84.24 ± 1.28 | 79.02 ± 2.35% | 62.18 ± 1.39% |
| PS (nm) | 358.60 ± 10.76 | 551.60 ± 23.84 | 197.05 ± 9.97 | 117.55 ± 5.44 | 287.25 ± 9.55 | 310.00 ± 8.16 |
| ZP (absolute -mV) | 30.00 ± 0.80 | 20.90 ± 0.55 | 66.95 ± 0.92 | 74.85 ± 1.91 | 36.15 ± 1.06 | 10.19 ± 0.2 |
| Release (8h) | < 40 % | not studied | 85.33 ± 1.35 | 77.95 ± 1.22 | >80% | not studied |
Abbreviations: EE %, percent entrapment efficiency; PS, particle size; ZP, zeta potential.
Nanosystems: O-NV, Ocular Novasomes; O-OLN, Ocular Olaminosomes; O-TP, Ocular Terpesomes; T-CE, Topical cerosomes; T-T-NV, Topical Trans-Novasomes; V-TP, Vaginal Terpesomes.